EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2050-7771
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies ; volume:6 ; number:1 ; day:7 ; month:12 ; year:2018 ; pages:1-10 ; date:12.2018
Biomarker Research ; 6, Heft 1 (7.12.2018), 1-10, 12.2018
- Urheber
-
Tremblay-LeMay, Rosemarie
Rastgoo, Nasrin
Pourabdollah, Maryam
Chang, Hong
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40364-018-0148-5
- URN
-
urn:nbn:de:101:1-2019012701455424731758
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tremblay-LeMay, Rosemarie
- Rastgoo, Nasrin
- Pourabdollah, Maryam
- Chang, Hong
- SpringerLink (Online service)
Ähnliche Objekte (12)
EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications
Breast imaging findings in haematological malignancies
Genes of multidrug resistance in haematological malignancies
Targeting hypoxia in solid and haematological malignancies
Asbestos exposure and haematological malignancies: a Danish cohort study
The Application of CAR-T Cells in Haematological Malignancies
COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches
Severe bleeding events among critically ill patients with haematological malignancies
Attitudes towards COVID-19 Vaccination in Adults with Haematological Malignancies
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review
ADP dependent glucokinase as a novel onco-target for haematological malignancies.
EZH2: novel therapeutic target for human cancer
EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications
Breast imaging findings in haematological malignancies
Genes of multidrug resistance in haematological malignancies
Targeting hypoxia in solid and haematological malignancies
Asbestos exposure and haematological malignancies: a Danish cohort study
The Application of CAR-T Cells in Haematological Malignancies
COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches
Severe bleeding events among critically ill patients with haematological malignancies
Attitudes towards COVID-19 Vaccination in Adults with Haematological Malignancies
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review
ADP dependent glucokinase as a novel onco-target for haematological malignancies.
EZH2: novel therapeutic target for human cancer
EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications
Breast imaging findings in haematological malignancies
Genes of multidrug resistance in haematological malignancies
Targeting hypoxia in solid and haematological malignancies
Asbestos exposure and haematological malignancies: a Danish cohort study
The Application of CAR-T Cells in Haematological Malignancies
COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches
Severe bleeding events among critically ill patients with haematological malignancies
Attitudes towards COVID-19 Vaccination in Adults with Haematological Malignancies
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review
ADP dependent glucokinase as a novel onco-target for haematological malignancies.